Owners, management and financials
CVR: 39606925
Secondary names: Biogenity Danmark ApS, Biogenity International ApS, Biogenity Copenhagen ApS
Previous names: Biogenity IVS
DKK 1,387,873
Gross profit
Net result: DKK -453,753
L.Loeb Holding ApS (50-66,65%), Kastaniegaard Holding ApS (50-66,65%)
CVR · view owners
Kenneth Kastaniegaard, Louis Loeb
Board: Louis Loeb (chair) and 1 member
CVR · view management
Active
Founded 30 May 2018
CVR · view overview
6 employees
CVR · 2026
Name registered: Biogenity ApS
CVR · 04/10/2019
View the full event history
Biogenity ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Biogenity IVS. The management consists of Kenneth Kastaniegaard and Louis Loeb. The board consists of Louis Loeb (chair) and Kenneth Kastaniegaard. The company is owned by L.Loeb Holding ApS and Kastaniegaard Holding ApS. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK 1,387,873 and a net result of DKK -453,753 compared with DKK -342,877 the year before. Equity in the 2025 report amounted to DKK -189,867.
Source: annual report 2025, Danish Business Authority
Biogenity ApS has shown a fluctuating financial trajectory since its inception in 2018, with notable volatility in profitability. In 2023, the company achieved a gross profit of 2,397,327 DKK and turned a profit of 449,314 DKK, marking a significant recovery from previous losses. However, the subsequent year saw a decline, with gross profit dropping to 1,387,873 DKK and a loss of 453,753 DKK in 2025. The equity position has also been unstable, moving from 606,762 DKK in 2023 to -189,867 DKK in 2025, raising concerns about its financial stability. Overall, while Biogenity ApS has potential within the research and experimental development sector, its inconsistent profitability and equity position suggest a need for strategic adjustments to ensure sustainable growth.
AI-generated summary · Generated 13/08/2026
Selskabets formål er at fungere som dataanalysebureau for den farmaceutiske industri.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/07/2024 – 30/06/2025 | 1.4 mio. | -454 t. | 1.8 mio. | -190 t. | 4 | |
| 202401/07/2023 – 30/06/2024 | 1.9 mio. | -343 t. | 1.1 mio. | 264 t. | 6 | |
| 202301/07/2022 – 30/06/2023 | 2.4 mio. | 449 t. | 1.5 mio. | 607 t. | 5 | |
| 202201/07/2021 – 30/06/2022 | 1.3 mio. | -108 t. | 650 t. | 143 t. | 5 | |
| 202101/07/2020 – 30/06/2021 | 97 t. | 117 t. | 502 t. | 250 t. | 3 | |
| 202001/07/2019 – 30/06/2020 | -115 t. | 72 t. | 323 t. | 133 t. | - | |
| 201930/05/2018 – 30/06/2019 | -71 t. | 141 t. | 184 t. | 141 t. | - |
Compared to 1.040 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorThe CVR number of Biogenity ApS is 39606925.
Biogenity ApS is owned by L.Loeb Holding ApS and Kastaniegaard Holding ApS.
The management of Biogenity ApS consists of Kenneth Kastaniegaard and Louis Loeb.
The board of Biogenity ApS consists of Louis Loeb and Kenneth Kastaniegaard, with Louis Loeb as chair.
In 2025, Biogenity ApS reported a gross profit of DKK 1,387,873.
Biogenity ApS had 6 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Biogenity ApS has published its annual report for 2025. Gross profit came to DKK 1,387,873, and the net result was DKK -453,753.
Biogenity ApS has published its annual report for 2024. Gross profit came to DKK 1,898,870, and the net result was DKK -342,877.
Biogenity ApS has published its annual report for 2023. Gross profit came to DKK 2,397,327, and the net result was DKK 449,314.
Biogenity ApS has published its annual report for 2022. Gross profit came to DKK 1,251,021, and the net result was DKK -107,560.
Biogenity ApS has published its annual report for 2021. Gross profit came to DKK 96,977, and the net result was DKK 117,322.
Biogenity ApS has published its annual report for 2020. Gross profit came to DKK -115,272, and the net result was DKK 71,526.
On October 4, 2019, the company changed its name from Biogenity IVS to Biogenity ApS.
Biogenity ApS has published its annual report for 2019. Gross profit came to DKK -71,498, and the net result was DKK 141,285.
As of June 25, 2019, Søren Buch Jensen has left the board of directors of Biogenity ApS.
As of June 25, 2019, Søren Buch Jensen has stepped down as director of Biogenity ApS.
As of April 1, 2019, Søren Buch Jensen has joined the board of directors of Biogenity ApS.
As of April 1, 2019, Søren Buch Jensen is registered as director of Biogenity ApS.
As of December 20, 2018, Louis Loeb has joined the board of directors of Biogenity ApS.
As of December 20, 2018, Søren Buch Jensen has left the board of directors of Biogenity ApS.
As of December 20, 2018, Søren Buch Jensen has stepped down as director of Biogenity ApS.
As of December 19, 2018, Louis Loeb has left the board of directors of Biogenity ApS.
As of May 30, 2018, Louis Loeb has joined the board of directors of Biogenity ApS.
As of May 30, 2018, Kenneth Kastaniegaard has joined the board of directors of Biogenity ApS.
As of May 30, 2018, Søren Buch Jensen has joined the board of directors of Biogenity ApS.
As of May 30, 2018, Louis Loeb is registered as director of Biogenity ApS.
As of May 30, 2018, Kenneth Kastaniegaard is registered as adm. dir. of Biogenity ApS.
As of May 30, 2018, Søren Buch Jensen is registered as director of Biogenity ApS.
As of May 30, 2018, L.Loeb Holding ApS is registered as an owner of Biogenity ApS with an ownership share of 50%.
As of May 30, 2018, Kastaniegaard Holding ApS is registered as an owner of Biogenity ApS with an ownership share of 50%.
Biogenity ApS was founded on May 30, 2018.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er besidde kapitalandele i datterselskaber og associerede selskaber samt at drive investeringsvirksomhed samt enhver i forbindelse hermed beslægtet virksomhed.
Companies in the same industry and area
CVR 33864884
CVR 36036869
CVR 38322761
CVR 40237216
CVR 41458534
